Cutaneous Manifestations among COVID-19 Patients Admitted to a COVID Hospital: A Retrospective Analysis
Authors/Creators
- 1. Senior Resident, Department of Skin and VD, Patna Medical College and Hospital
- 2. Assistant Professor, Department of Skin and VD, Patna Medical College and Hospital
Description
Since the emergence of the COVID-19 pandemic, various cutaneous manifestations have been reported among infected individuals. Understanding these dermatological symptoms is crucial for early recognition, diagnosis, and appropriate management. This retrospective study investigated the prevalence and types of cutaneous manifestations observed among COVID-19 patients admitted to a designated COVID hospital in Bihar, India. Medical records of COVID-19 patients admitted to the COVID hospital between August 2022 and July were retrospectively reviewed. Patients with documented cutaneous manifestations during their hospitalization were included in the study. Data on patient demographics, clinical characteristics, and dermatological findings were collected and analysed. This study included 500 patients with moderate-to-severe COVID-19, where more than half were aged >60 years, and 48% exhibited severe cutaneous manifestations, with erythematous rash (38%) being the most common symptom, while vesicular lesions were associated with severe COVID-19, and erythematous rash and urticaria with mild-to-moderate disease, and post-COVID-19 skin complications were reported in 15% of recovered patients, with post-inflammatory hyperpigmentation (7%) and pruritus (5%) being the most common. This retrospective study sheds light on the occurrence of cutaneous manifestations in COVID-19 patients admitted to a COVID hospital in Bihar, India. Early recognition of these dermatological signs is crucial for timely diagnosis and appropriate management. Further research is warranted to investigate the underlying mechanisms and potential implications of these cutaneous symptoms in the context of COVID-19.
Abstract (English)
Since the emergence of the COVID-19 pandemic, various cutaneous manifestations have been reported among infected individuals. Understanding these dermatological symptoms is crucial for early recognition, diagnosis, and appropriate management. This retrospective study investigated the prevalence and types of cutaneous manifestations observed among COVID-19 patients admitted to a designated COVID hospital in Bihar, India. Medical records of COVID-19 patients admitted to the COVID hospital between August 2022 and July were retrospectively reviewed. Patients with documented cutaneous manifestations during their hospitalization were included in the study. Data on patient demographics, clinical characteristics, and dermatological findings were collected and analysed. This study included 500 patients with moderate-to-severe COVID-19, where more than half were aged >60 years, and 48% exhibited severe cutaneous manifestations, with erythematous rash (38%) being the most common symptom, while vesicular lesions were associated with severe COVID-19, and erythematous rash and urticaria with mild-to-moderate disease, and post-COVID-19 skin complications were reported in 15% of recovered patients, with post-inflammatory hyperpigmentation (7%) and pruritus (5%) being the most common. This retrospective study sheds light on the occurrence of cutaneous manifestations in COVID-19 patients admitted to a COVID hospital in Bihar, India. Early recognition of these dermatological signs is crucial for timely diagnosis and appropriate management. Further research is warranted to investigate the underlying mechanisms and potential implications of these cutaneous symptoms in the context of COVID-19.
Files
IJPCR,Vol15,Issue9,Article13.pdf
Files
(2.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:97ff7460e90bf1c61ee70e4c7ae8516c
|
2.1 MB | Preview Download |
Additional details
Dates
- Accepted
-
2023-08-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue9,Article13.pdf
- Development Status
- Active
References
- 1. Coronavirus Disease (COVID-19) - Events as They Happen [Internet]. Rolling Updates on Coronavirus Disease (COVID-19)., World Health Organization, 2020. 2. Han Y, Yang H. The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID‐19): A Chinese perspective. Journal of Medical Virology 2020; 92:639–44. 3. Tahvildari A, Arbabi M, Farsi Y, Jamshidi P, Hasanzadeh S, Calcagno TM, et al. Clinical Features, Diagnosis, and Treatment of COVID-19 in Hospitalized Patients: A Systematic Review of Case Reports and Case Series. Frontiers in Medicine 2020; 7. 4. Giavedoni P, Podlipnik S, Pericàs JM, Fuertes de Vega I, García-Herrera A, Alós L, et al. Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity. Journal of Clinical Medicine 2020; 9:3261. 5. Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol. 2020 34:e250–1. 6. Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. Journal of the European Academy of Dermatology and Venereology 2020; 34. 7. Diaz-Guimaraens B, Dominguez-Santas M, Suarez-Valle A, Pindado-Ortega C, SeldaEnriquez G, Bea-Ardebol S, et al. Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. JAMA Dermatology 2020; 156:820. 8. Piccolo V, Neri I, Filippeschi C, Oranges T, Argenziano G, Battarra VC, et al. Chilblain‐ like lesions during COVID‐19 epidemic: a preliminary study on 63 patients. Journal of the European Academy of Dermatology and Venereology 2020; 34. 9. Young S, Fernandez AP. Skin manifestations of COVID-19. Cleveland Clinic Journal of Medicine 2020. 10. Priyadarshini, S. Chaudhury. The Return of Bihari Migrants after the COVID-19 Lockdown. India's Migrant Workers and the Pandemic, Routledge. 2021; 191-204. 11. Chandramouli, R. General. Census of India 2011, Provisional Population Totals, Government of India, New Delhi. 2011; 409-413. 12. Alshiyab DM, Al-qarqaz FA, Alhaje E, Mayou JA, Jaradat S, Asaad A, et al. Skin Manifestations Among Patients Admitted with COVID-19: A Cross-Sectional Study at a University-Based Tertiary Hospital in Jordan. Clinical, Cosmetic and Investigational Dermatology 2023; Volume 16:1331–40. 13. Imen Y, Mechergui N, Litaiem N, Youssef I, Gara S, Zeglaoui F, et al. Cutaneous manifestations of COVID‐19 among healthcare workers: A Case report and literature review. Clinical Case Reports 2022; 10. 14. Dezoteux F, Mille B, Fievet C, Moreau A-S, DUHAMEL A, Drumez E, et al. Vascular skin manifestations in patients with severe COVID19 in intensive care units: a monocentric prospective study. European Journal of Dermatology 2021; 31:508–13. 15. Tan CC, Dofitas BL, Frez MaLF, Yap CDD, Uy JKK, Ciriaco-Tan CP. Cutaneous manifestations of COVID-19 in a tertiary COVID-19 referral hospital in the Philippines. JAAD International 2022; 7:44–51. 16. Sameni F, Hajikhani B, Yaslianifard S, Goudarzi M, Owlia P, Nasiri MJ, et al. COVID-19 and Skin Manifestations: An Overview of Case Reports/Case Series and Meta-Analysis of Prevalence Studies. Frontiers in Medicine 2020;7. 17. Agnihothri R, Fox LP. Clinical Patterns and Morphology of COVID-19 Dermatology. Dermatologic Clinics 2021; 39:487–503.